SavedAdd your journal

Journals / Journal of Basic and Clinical Health Sciences / 2023 / Cilt: 7 Sayı: 2

Geri Çekildi: Is the Occurrence of Gestational Diabetes Mellitus in Pregnancies Higher Following In Vitro Fertilization Treatment? Why? A Retrospective Cohort Study

Geri Çekildi:

Nuran Nur AYPAR AKBAĞ
Merlinda ALUŞ TOKAT
Sevcan FATA
Elif ÜNSAL AVDAL
Emre OKYAY
Ömer Erbil DOĞAN
Pages
553–553
Publication Date
2023-05-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: As age and number of IVF trials increase in infertile women, the risk of GDM increases after IVF treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: This study aim to determine the occurrence of gestational diabetes mellitus (GDM) in pregnancies after IVF treatment and to evaluate the factors that reduce this risk.
📊
Key Findings & Data:Methods: This retrospective cohort study was conducted using the medical records of pregnant women who conceived following IVF at the in-vitro fertilization center between 2002–2019.
💡
Conclusion & Impact:Conclusion: As age and number of IVF trials increase in infertile women, the risk of GDM increases after IVF treatment.
🔬Design:Modeling & Simulation
📍Scope:2002–2019 Verileri
⚙️Variables:Gestational Diabetes Mellitus · In Vitro Fertilization · Risk Factors

Abstract

Purpose: This study aim to determine the occurrence of gestational diabetes mellitus (GDM) in pregnancies after IVF treatment and to evaluate the factors that reduce this risk. Methods: This retrospective cohort study was conducted using the medical records of pregnant women who conceived following IVF at the in-vitro fertilization center between 2002–2019. The data were obtained from medical records and phone interviews. Univariate and multivariate logistic regression analyses were performed. Results: The incidence of GDM was found to be 16.7%. The regression model indicated that the risk of GDM was 4.57 times higher in the age group 36–40 at conception during the IVF cycle than the age group 31–35 (95% CI = 1.18–17.73, p = .028). Furthermore, women who conceived after the second IVF trial had a risk of GDM 3.464 times higher than those that conceived after their first IVF trial (95% CI = 1.07–11.23, p= .038). Conclusion: As age and number of IVF trials increase in infertile women, the risk of GDM increases after IVF treatment.

🔖

Cite This Article

AKBAĞ, N. N. A., TOKAT, M. A., FATA, S., AVDAL, E. Ü., OKYAY, E., DOĞAN, Ö. E. (2023). Geri Çekildi: Is the Occurrence of Gestational Diabetes Mellitus in Pregnancies Higher Following In Vitro Fertilization Treatment? Why? A Retrospective Cohort Study. Journal of Basic and Clinical Health Sciences, Cilt: 7 Sayı: 2, 553–553. https://ajindex.com/articles/939949

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nature Reviews Disease Primers 2019; 5:47
  2. International Diabetes Federation (IDF). IDF Diabetes Atlas. 8th ed. 2017
  3. Karaçam Z, Çelik D. The prevalence and risk factors of gestational diabetes mellitus in Turkey: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2019; 2:1-11
  4. Johns EC, Denison FC, Norman JE, Reynolds RM. Gestational Diabetes Mellitus: Mechanisms, Treatment, and Complications. Trends in Endocrinology & Metabolism 2018; 29 (11): 743-754
  5. Hoseini S, Hantoushzadeh S, Shoar S. Evaluating the extent of pregravid risk factors of gestational diabetes mellitus in women in Tehran. Iran Red Crescent Med J 2011; 13:407–14
  6. American Diabetes Association (ADA). Gestational diabetes mellitus. Diabetes Care 2004; 27(1): 88–90
  7. Allen C, Bowdin S, Harrison RF, et al. Pregnancy and perinatal outcomes after assisted reproduction: a comparative study. Ir J Med Sci 2008; 177:233–241
  8. Palomba S, Homburg R, Santagni S, La Sala GB, Orvieto R. Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review. Reprod Biol Endocrinol 2016; 14(1):76
  9. Sabban H, Zakhari A, Patenaude V, Tulandi T, Abenhaim HA. Obstetrical and perinatal morbidity and mortality among in-vitro fertilization pregnancies: a population-based study. Arch Gynecol Obstet 2017; 296:107–113
  10. Storgaard M, Loft A, Bergh C, et al. Obstetric and neonatal complications in pregnancies conceived after oocyte donation: a systematic review and meta-analysis. BJOG 2017; 124:561–572
  11. Jones BJ, Zollner J, Haynes S, Cheng F, Dornhorst A. In vitro fertilization treatment influences glucose tolerance in multiple pregnancy. Diabetic Medicine 2013;30(2):252–254
  12. Ashrafi M, Gosili R, Hosseini R, Arabipoor A, Ahmadi J, Chehrazi M. Risk of gestational diabetes mellitus in patients undergoing assisted reproductive techniques. Eur J Obstet Gynecol Reprod Biol 2014; 176:149–152
  13. Zhu L, Zhang Y, Liu Y, et al. Maternal and live-birth outcomes of pregnancies following assisted reproductive technology: a retrospective cohort study. Sci Rep 2016; 6:35141
  14. Qin J, Liu X, Sheng X, Wang H, Gao S. Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a metaanalysis of cohort studies. Fertil Steril 2016; 105(1):73–85
  15. Cai S,